The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

Up to $40 Million Private Equity Financing into a New Entity Addressing Cardiac Genetic Diseases that Existing AAV Platforms ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Researchers discovered that HSV-1 (herpes simplex virus) actively reshapes the 3D layout of human DNA within hours of ...

Plant RNA viruses pose a significant threat to global agriculture, affecting a vast array of crop species and leading to ...

Scientists in Spain and China discovered that HSV-1 begins rewriting the architecture of human genes just one hour after ...

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely ...

Cold sore-causing HSV-1 doesn't just hijack cells it reconfigures the entire architecture of our DNA to aid its invasion.

New research has discovered that the Herpes virus actually takes control of key RNA functionality and changes human DNA in ...

The herpes virus that commonly causes cold sores affects how tightly coiled our DNA is and makes it shrink, all to help itself grow ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...